The Shift in Global Drug Development
2026-04-29 · 58 min · episode 1091 · 13 entities
Asserted relationships
-
0.77
evidence rules-v4
Link in episode "The Shift in Global Drug Development": https://x.com/gbrl_dick
-
0.55
evidence rules-v4
Feed author/publisher: Andreessen Horowitz
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: Business
-
0.40
evidence rules-v4
Feed category: Entrepreneurship
-
0.40
evidence rules-v4
Feed author/publisher: a16z
Entities found in this episode
concepts 8
-
0.50
evidence rules-v4
Feed category: Science
-
0.50
evidence rules-v4
Feed category: Technology
-
0.50
evidence rules-v4
Feed category: Business
-
0.50
evidence rules-v4
Feed category: Entrepreneurship
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: Business
-
0.40
evidence rules-v4
Feed category: Entrepreneurship
persons 4
-
0.90
evidence rules-v4
Link in episode "The Shift in Global Drug Development": https://x.com/gbrl_dick
-
0.77
evidence rules-v4
Link in episode "The Shift in Global Drug Development": https://x.com/gbrl_dick
-
0.70
evidence rules-v4
Feed author/publisher: Andreessen Horowitz
-
0.55
evidence rules-v4
Feed author/publisher: Andreessen Horowitz
companys 1
-
0.40
evidence rules-v4
Feed author/publisher: a16z
Episode description as stored
Theo Jaffee and Gabriel Dickinson speak with Cremieux about China’s rapid rise to the top of global clinical trial output. They discuss the regulatory reforms that accelerated China’s progress, the surge in novel drug development, and what the US would need to change to stay competitive in biomedical innovation.
Resources:
Follow Cremieux on X: https://x.com/cremieuxrecueil
Follow Theo on X: https://x.com/theojaffee
Follow Gabriel on X: https://x.com/gbrl_dick
Stay Updated:
Find a16z on YouTube: YouTube
Find a16z on X
Find a16z on LinkedIn
Listen to the a16z Show on Spotify
Listen to the a16z Show on Apple Podcasts
Follow our host: https://twitter.com/eriktorenberg
Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.